New app helps Sherman elementary school with flu prevention

Blue Bell: Testing helps create safe treats post-2015 recall

Blue Bell issues cookie dough ice cream recall

Grayson County reports first West Nile Virus death

Blue Bell issues chocolate chip cookie dough ice cream recall

Grayson College treating three buildings for mold

Zika mosquito in Ardmore

Big Food's biggest trend? Crusading against Big Food

City of Denison breaks ground on new park

Grayson Co. reports first human West Nile case of 2016

Local mosquito control company shares how to stay safe during spraying

City of Van Alstyne to spray Monday night for mosquitoes

Mylan launching cheaper, generic version of EpiPen

Pilot Point spraying for mosquitoes after confirmed Zika case

More Grayson County test pools positive for West Nile virus

U.S. government won't reclassify marijuana, allows research

City of Ada keeps ambulances running

Medicare releases hospital ratings

Load More Stories

CBS News Health Headlines

A certain combination of factors at work could take a toll on your health
Electric bikes, called e-bikes, leave people smiling – here's why
Study author says the results “really challenge what is typical practice today by headache specialists"
A new study looks at what might happen if the timeline for heart disease prevention was moved up – way up

WebMD Health News

father kissing newborn baby

Tips to soothe your little one and ease your stress during vaccinations.

women hugging holding water bottles

A WebMD reader shares how medication and a strong support system lead to her success.

Bacteria on skin sometimes release fatty acids that trigger inflammation, researchers report


Because bipolar depression can resemble other conditions, see your doctor or mental health professional to get a correct diagnosis.

Woman Gets $70M in Baby Powder/Ovarian Cancer Suit

AP Top Health Stories

By Andrew M. Seaman (Reuters Health) - Injecting men with two different hormones every eight weeks suppressed their sperm production enough to act as birth control, according to a new study. An independent safety board found that side effects, which included depression and other mood disorders, outweighed the potential benefits of the injections. Every eight weeks, the men received injections of long-acting testosterone and progestin.
By Lisa Rapaport (Reuters Health) - Medicare penalties are tied to fewer repeat hospitalizations for some common health problems, but a new study suggests current policy doesn’t encourage hospitals in the United States to focus on preventable deaths. Researchers examined nationwide data for both deaths and readmissions within 30 days of discharge for three common problems: heart failure, pneumonia and heart attacks. About 17 percent of U.S. hospitals are getting punished for excess readmissions even though they’re keeping patients alive more often than would be expected, the analysis found.

A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in WashingtonBy Caroline Humer and Ruthy Munoz NEW YORK/WASHINGTON (Reuters) - Mylan NV's price hikes on EpiPens have added millions to U.S. Department of Defense spending since 2008 as the agency covered more prescriptions for the lifesaving allergy shot at near retail prices, government data provided to Reuters shows. Pentagon spending rose to $57 million over the past year from $9 million in 2008 - an increase driven both by volume and by price hikes that had a bigger bite on prescriptions filled at retail pharmacies, according to the previously unreported data. The Pentagon gets a government discount on EpiPens dispensed at military treatment facilities and by mail order.

The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the NYSEMedical device maker St. Jude Medical Inc said on Friday it has notified doctors to stop implants of one of its cardiac pacemakers, citing reports of problems with electronic data reporting caused by a battery malfunction that could put patients at risk. The affected device is the Nanostim leadless cardiac pacemaker (LCP). St. Jude, which is being acquired by Abbott Laboratories, said it had seven reports of lost telemetry and heart pacing output from the devices.

(Reuters) - The U.S. Food and Drug Administration today approved St. Jude Medical Inc's device to prevent recurrent strokes in certain patients. The device, amplatzer PFO occluder, has been approved for patients who previously had a stroke due to a blood clot that passed through a small hole in the heart and then traveled to the brain. ( (Reporting by Dipika Jain in Bengaluru; Editing by Shounak Dasgupta)